FDA
-
-
-
-
-
-
-
Rein Therapeutics gets FDA clearance to restart Phase 2 IPF trial
-
-
-
-
-
-
-
Rein Therapeutics Announces Initiation of RENEW Phase 2 Trial of LTI-03 in Patients with IPF
-
-
-
-
-
-
-
Aileron Therapeutics Announces Rebranding to Rein Therapeutics
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

